Shree Ganesh Bio — 360° view

Shree Ganesh Bio, a company in the Biotechnology industry, reported revenue of ₹0.16 crore and a net loss of ₹0.08 crore for the September 2026 quarter.

Shree Ganesh Bio (BSE: SHREEGANES) closed at ₹0.44 on 20 Nov 2026, down 34.3% over the past year. Its market capitalisation is ₹18 crore.

Share price
₹0.44 (20 Nov 2026)
Market cap
₹18 Cr (20 Nov 2026)
Revenue
₹0 Cr (September 2026 quarter)
Net profit
₹-0 Cr (September 2026 quarter)
ROCE
1.31% (FY26)
ROE
0.96% (FY26)
Book value
₹1.58 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹0.75 / ₹0.40 (20 Nov 2026)
1-year return
-34.3% (to 20 Nov 2026)
Sector
Healthcare
Industry
Biotechnology
Symbol
BSE: SHREEGANES

Incorporated in 1982, Shree Ganesh Biotech Ltd is engaged in the trading of seeds and bhushi.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.